These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 27492720

  • 21. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides.
    Karteris E, Vatish M, Hillhouse EW, Grammatopoulos DK.
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3680-7. PubMed ID: 15784708
    [Abstract] [Full Text] [Related]

  • 22. Placental urocortins and CRF in late gestation.
    Pepels PP, Spaanderman ME, Bulten J, Smits PB, Hermus AR, Lotgering FK, Sweep CG.
    Placenta; 2009 Jun; 30(6):483-90. PubMed ID: 19359038
    [Abstract] [Full Text] [Related]

  • 23. Galectin-1 overexpression in endometriosis and its regulation by neuropeptides (CRH, UCN) indicating its important role in reproduction and inflammation.
    Vergetaki A, Jeschke U, Vrekoussis T, Taliouri E, Sabatini L, Papakonstanti EA, Makrigiannakis A.
    PLoS One; 2014 Jun; 9(12):e114229. PubMed ID: 25473847
    [Abstract] [Full Text] [Related]

  • 24. Characterising the corticotropin-releasing hormone (CRH) receptors mediating CRH and urocortin actions during human pregnancy and labour.
    Hillhouse EW, Grammatopoulos DK.
    Stress; 2001 Dec; 4(4):235-46. PubMed ID: 22432144
    [Abstract] [Full Text] [Related]

  • 25. UCN2: a new candidate influencing pancreatic β-cell adaptations in pregnancy.
    Simpson SJS, Smith LIF, Jones PM, Bowe JE.
    J Endocrinol; 2020 May; 245(2):247-257. PubMed ID: 32106091
    [Abstract] [Full Text] [Related]

  • 26. Stress regulation of WFS1 and PERK-p-eIF2α-ATF4 signaling pathway in placental tissue cells of intrahepatic cholestasis of pregnancy.
    Chen D, Xu T, Li Y, Xu J, Peng B, Xu W, Wang X.
    Placenta; 2023 Aug; 139():1-11. PubMed ID: 37269649
    [Abstract] [Full Text] [Related]

  • 27. Second-trimester amniotic fluid corticotropin-releasing hormone and urocortin in relation to maternal stress and fetal growth in human pregnancy.
    La Marca-Ghaemmaghami P, Dainese SM, Stalla G, Haller M, Zimmermann R, Ehlert U.
    Stress; 2017 May; 20(3):231-240. PubMed ID: 28347187
    [Abstract] [Full Text] [Related]

  • 28. Corticotropin-releasing hormone and urocortin promote phagocytosis of rat macrophages through convergent but distinct pathways.
    Wang WC, Zhang XZ, Liu DW, Qiu J, Wang XH, Zhou JH.
    Life Sci; 2015 Feb 01; 122():100-7. PubMed ID: 25534437
    [Abstract] [Full Text] [Related]

  • 29. Urocortin in human placenta and maternal plasma.
    Watanabe F, Oki Y, Ozawa M, Masuzawa M, Iwabuchi M, Yoshimi T, Nishiguchi T, Iino K, Sasano H.
    Peptides; 1999 Feb 01; 20(2):205-9. PubMed ID: 10422876
    [Abstract] [Full Text] [Related]

  • 30. Expression of urocortin and corticotropin-releasing hormone receptors in the horse thyroid gland.
    Squillacioti C, De Luca A, Alì S, Paino S, Liguori G, Mirabella N.
    Cell Tissue Res; 2012 Oct 01; 350(1):45-53. PubMed ID: 22684850
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Modulation of corticotropin-releasing hormone type 2 receptor and urocortin 1 and urocortin 2 mRNA expression in the cardiovascular system of prairie voles following acute or chronic stress.
    Pournajafi-Nazarloo H, Partoo L, Sanzenbacher L, Azizi F, Carter CS.
    Neuroendocrinology; 2007 Oct 01; 86(1):17-25. PubMed ID: 17551267
    [Abstract] [Full Text] [Related]

  • 34. Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility.
    Karteris E, Hillhouse EW, Grammatopoulos D.
    Endocrinology; 2004 Feb 01; 145(2):890-900. PubMed ID: 14592950
    [Abstract] [Full Text] [Related]

  • 35. Modulation of corticotropin-releasing hormone receptor type 2 mRNA expression by CRH deficiency or stress in the mouse heart.
    Pournajafi Nazarloo H, Tanaka Y, Dorobantu M, Hashimoto K.
    Regul Pept; 2003 Sep 15; 115(2):131-8. PubMed ID: 12972328
    [Abstract] [Full Text] [Related]

  • 36. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors.
    Singh LK, Boucher W, Pang X, Letourneau R, Seretakis D, Green M, Theoharides TC.
    J Pharmacol Exp Ther; 1999 Mar 15; 288(3):1349-56. PubMed ID: 10027877
    [Abstract] [Full Text] [Related]

  • 37. mRNA expression profiles for corticotrophin-releasing hormone, urocortin, CRH-binding protein and CRH receptors in human term gestational tissues determined by real-time quantitative RT-PCR.
    Sehringer B, Zahradnik HP, Simon M, Ziegler R, Noethling C, Schaefer WR.
    J Mol Endocrinol; 2004 Apr 15; 32(2):339-48. PubMed ID: 15072543
    [Abstract] [Full Text] [Related]

  • 38. Changes in placental CRH, urocortins, and CRH-receptor mRNA expression associated with preterm delivery and chorioamnionitis.
    Torricelli M, Novembri R, Bloise E, De Bonis M, Challis JR, Petraglia F.
    J Clin Endocrinol Metab; 2011 Feb 15; 96(2):534-40. PubMed ID: 21106714
    [Abstract] [Full Text] [Related]

  • 39. [Action of corticotropin-releasing hormone on its own receptor type-1 in human placenta].
    Wang XD, Yu HY, He MM, Liu SY.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan 15; 38(1):101-4. PubMed ID: 17294739
    [Abstract] [Full Text] [Related]

  • 40. [Expression of corticotropin-releasing hormone receptor type-1 in intrahepatic cholestatic placental tissue].
    Liu ZF, He MM, Zhou F, Gao BX, Wang XD.
    Zhonghua Gan Zang Bing Za Zhi; 2013 May 15; 21(5):381-4. PubMed ID: 24025142
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.